Gestational Diabetes Risks Prevention and Treatments
Attributes to meet: PDF: Download File, Reports
Download File: condition met
Literature Review, 2020
Gestational diabetes, also known as gestational diabetes mellitus (GDM), is a sub-type of diabetes that is first identified during pregnancy. It consists of abnormal glucose tolerance or higher than normal blood glucose levels, that may or may not diminish following the birth of an infant. Over the past decades, GDM rates have continued to increase in Canada. This review provides information on the risk factors for developing GDM, its impact on maternal and offspring health, the approach to screening and diagnosis, recommended management strategies (both pharmacological and non-pharmacological), as well as primary prevention strategies.
Related products
Infant Mortality in Saskatchewan: Evidence to Inform Public Health Practice
Report, 2009
This document was prepared to describe the relationship between modifiable risk factors and infant mortality. It is meant to provide guidance, strategies, and support to help expand or develop programs that may contribute to the reduction of infant mortality in Saskatchewan. It includes a review of the literature regarding prevalent risk factors associated with infant mortality, as well as identifying promising practices related to those modifiable risk factors.
SKU: 2-457
Group Prenatal Care Lit Review
Report, 2016
Group prenatal care is a model of group where eight to twelve women of similar gestational age meet as a group with their healthcare provider for 90-120 minutes of regularly scheduled appointments, starting in their second trimester and continuing throughout their pregnancy. During these appointments, each woman has a brief individual physical assessment with the healthcare provider and then participates in a group discussion led by a healthcare provider. All prenatal care is provided in this group setting, combining the usual physical assessment with peer support and increased time for education about healthy pregnancy. This report examines current research on group prenatal care to assess if it is a good model of care for Saskatchewan and if there is an improvement in birth outcomes and breastfeeding rates associated with using this model of care compared to individual prenatal care. Birth outcomes examined in this report are gestational age at birth, preterm birth, and low birth weight.
SKU: 2-903
HIV, Pregnancy, and Tobacco Use
Poster, 2023
This poster explains that for women living with HIV, smoking tobacco during pregnancy can increase the chances that HIV will be passed to the baby. Supports are listed to help pregnant women and those planning a pregnancy to quit or reduce their tobacco use.
SKU: 7-517
Substance Use, Pregnancy, and HIV/AIDS: Treatment Programs for Pregnant Women
Report, 2012
This living document identifies existing substance use treatment programs and services available to pregnant women and pregnant women living with HIV/AIDS in North America, with a particular focus on Saskatchewan. The information provided through the current environmental scan is useful both for pregnant women who use substances who are seeking services, and for healthcare professionals, who can use this information to assist women in accessing services that are appropriate to their needs. Ideally, this would be done as part of a multidisciplinary team, where the referring professional continues to be involved in the care of the woman. It is hoped that the information provided will increase awareness of the existing substance use treatment centres and programs for pregnant women, with the goal of potentially increasing referrals to and use of these programs.
SKU: 7-509